Targeted IL-1 inhibition

作者: Cem Gabay

DOI: 10.1007/978-3-0348-7883-8_3

关键词:

摘要: Interleukin (IL)-lα and IL-1β are produced by two different genes share 26% amino acid homology. Both forms synthesized as 31 kDa precursor peptides (pro-IL-lα pro-IL-1β), which specifically cleaved to generate 17 proteins for mature IL-lα IL-1β. is primarily macrophages secreted after cleavage of its proform IL-1β-convertase enzyme (ICE, also termed caspase 1). In addition, other enzymes in the absence ICE can process pro-IL-1β [1, 2]. without a hydrophobic leader peptide thus does not follow typical secretion pathway. Recently it has become apparent that be either through exocytosis endoplasmic vesicles or rapidly released microvesicles budding off cell membrane [3, 4]. contrast, expressed intracellular membrane-bound protein human. An important distinction between these molecules biologically inactive, whereas both pro-IL-lα exhibit full receptor binding activity. biologic effects following binding, exerts functions inside cells [5-7].

参考文章(69)
M. L. Ho, J. R. Jackson, N. Wei, J. D. Winkler, J. A. L. Minton, Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. The Journal of Rheumatology. ,vol. 24, pp. 1253- 1259 ,(1997)
Detlef Neumann, Christian Kollewe, Michael U. Martin, Diana Boraschi, The Membrane Form of the Type II IL-1 Receptor Accounts for Inhibitory Function Journal of Immunology. ,vol. 165, pp. 3350- 3357 ,(2000) , 10.4049/JIMMUNOL.165.6.3350
G S Firestein, A E Berger, M M Paine, N J Zvaifler, D L Chapman, C Yu, D E Tracey, J G Chosay, IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. Journal of Immunology. ,vol. 149, pp. 1054- 1062 ,(1992)
C A Dinarello, A R Rabson, E V Granowitz, S M Wolff, J B Angel, A E Chernoff, J S Kennedy, G Lonnemann, E Vannier, L Shapiro, A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses. Journal of Immunology. ,vol. 154, pp. 5492- 5499 ,(1995)
Gaby Palmer, Pierre-Andre Guerne, Francoise Mezin, Michel Maret, Jerome Guicheux, Mary B Goldring, Cem Gabay, Production of interleukin-1 receptor antagonist by human articular chondrocytes. Arthritis Research & Therapy. ,vol. 4, pp. 226- 231 ,(2002) , 10.1186/AR411
C G Figdor, J Culpepper, J E de Vries, R de Waal Malefyt, W Dang, G Zurawski, B Bennett, S Mohan-Peterson, R Huijbens, Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. Journal of Immunology. ,vol. 151, pp. 6370- 6381 ,(1993)
A E Berger, D L Chapman, J C McGuire, R N McEwan, D B Carter, R F Krzesicki, C A Hatfield, G E Winterrowd, J G Chosay, M J Bienkowski, Regulation of expression of IL-1 receptor antagonist protein in human synovial and dermal fibroblasts. Journal of Immunology. ,vol. 150, pp. 4008- 4018 ,(1993)
Uwe Schönbeck, François Mach, Peter Libby, Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. Journal of Immunology. ,vol. 161, pp. 3340- 3346 ,(1998)